Close

Celldex Completes Accrual of CDX-011 Phase 2b “EMERGE” Study in Advanced Breast Cancer Dec 21, 2011 08:00AM
Celldex Therapeutics Presents Novel Preclinical Data on CDX-1127 at the American Society of Hematology Meeting in San Diego Dec 12, 2011 08:00AM
 Celldex Initiates ACT IV, a Pivotal International Phase 3 Trial of Rindopepimut in Patients with Glioblastoma Dec 1, 2011 08:00AM
Celldex Therapeutics Reports Positive Mature Survival Data from Rindopepimut Phase 2 Brain Cancer Study at SNO 2011 Nov 21, 2011 08:00AM
Celldex Therapeutics Announces Initiation of Phase 1 Clinical Trial of CDX-1127 Nov 8, 2011 08:00AM


Nov 2, 2011 07:00AM Celldex Reports Third Quarter 2011 Financial Results
Oct 31, 2011 08:00AM Celldex Therapeutics Announces Orphan Drug Designation in the European Union for Rindopepimut, a Novel EGFRvIII Vaccine for Glioblastoma
Oct 25, 2011 08:00AM Celldex Therapeutics to Participate on Business Development Panel at BIO-Europe® 2011 in Duesseldorf, Germany
Aug 17, 2011 07:35AM Needham & Company Maintains a 'Buy' on Celldex Therapeutics (CLDX); Management Focus Grows on Upcoming Phase 3 Rindopepimut Trial Initiation
Jun 23, 2011 07:35AM Needham & Company Reiterates a 'Buy' on Celldex Therapeutics (CLDX); Five Themes Emerged That We Believe Deserve Increased Attention
May 5, 2011 08:19AM Needham & Company Reiterates a 'Buy' on Celldex Therapeutics (CLDX); Pivotal Trial of Rindopepimut in GBM On Track to Start in 2H11
Apr 12, 2011 07:39AM Needham & Company on Biotechnology & Life Sciences: Oncology / Hematology Review from the 2011 Needham Healthcare Conference
Mar 4, 2011 08:44AM Needham & Company Reiterates a 'Buy' on Celldex Therapeutics (CLDX); As CLDX Prepares to Start a Pivotal Trial of Rindopepimut in GBM, CDX-011 in Breast Cancer (Phase 2b) & Other Pipeline Products Adv
Jan 5, 2011 08:03AM Needham & Company Reiterates a 'Buy' on Celldex Therapeutics (CLDX); As the Company Prepares to Start a Pivotal Trial of Rindopepimut in GBM, Other Pipeline Products Continue to Advance
Nov 22, 2010 07:59AM Needham & Company reiterates a 'Buy' on Celldex Therapeutics (CLDX); Freezing Weather/Warming Data - Phase 2 Results Presented at the Montreal SNO Meeting Confirm Rindopepimut Potential
Aug 5, 2010 08:08AM Needham & Company Reiterates a 'Buy' on Celldex Therapeutics (CLDX); Internal Phase 2 Programs Continue to Advance
May 21, 2010 10:25AM 2010 ASCO Meeting Preview - Needham & Co Highlights ArQule (ARQL), Celldex (CLDX), Pharmacyclics (PCYC), and Seattle Genetics (SGEN)
Mar 5, 2010 08:12AM Needham & Company Reiterates a 'Buy' on Celldex Therapeutics (CLDX); Lowers PT
Jul 23, 2009 10:01AM Needham Comments on "Who's Next" In Biotech After Bristol-Myers (BMY) Buys Medarex (MEDX)
May 5, 2009 02:20PM Needham & Co. Upgrades Celldex Therapeutics (CLDX) to Buy
Dec 19, 2008 11:43AM Needham & Co Downgrades Celldex Therapeutics (CLDX) to Hold